Riley Ennis
Riley Ennis is founder of biotech startup Immudicon and was recently
selected as a Thiel Fellow in 2013. The company was founded based on
three years of research on a cancer vaccine technology that teaches the
immune cells of the body to recognize and remove tumors. He has been
recognized by CNN, Google X, ABC, the American Society of Microbiology,
Verizon Powerful Answers, Fox News, the GE Focus Forward Competition,
the Intel International Science Fair, and the National Young Inventors
Gallery. Before starting the Thiel Fellowship in 2013, Riley was a
Junior at Dartmouth College, pursuing a double major in economics and
biology, where he worked at the Dartmouth Hitchcock-Medical Center on
cancer nanotechnology research projects as a Dartmouth Science Scholar.